PortfoliosLab logoPortfoliosLab logo
BIVRX vs. FSCEX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BIVRX vs. FSCEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invenomic Fund (BIVRX) and Fidelity Advisor Small Cap Fund Class C (FSCEX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BIVRX achieves a 7.84% return, which is significantly lower than FSCEX's 19.16% return.


BIVRX

1D
-5.65%
1M
15.64%
6M
11.37%
YTD
7.84%
1Y
16.84%
3Y*
2.71%
5Y*
13.00%
10Y*
ALL TIME*
15.03%

FSCEX

1D
1.53%
1M
-1.83%
6M
13.88%
YTD
19.16%
1Y
31.96%
3Y*
6.45%
5Y*
3.01%
10Y*
7.82%
ALL TIME*
8.44%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$0.00$0.00$0.00
$0.00$0.00$0.00

BIVRX vs. FSCEX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BIVRX
Invenomic Fund
7.84%4.39%-9.03%16.47%49.61%44.06%11.12%11.36%3.41%8.73%
FSCEX
Fidelity Advisor Small Cap Fund Class C
19.16%11.04%-11.92%17.31%-21.33%30.13%16.12%31.37%-16.86%8.01%

Correlation

The correlation between BIVRX and FSCEX is -0.35, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.35

Correlation (3Y)
Balances recent behavior with more history.

-0.17

Correlation (5Y)
Shows whether the relationship held over a longer period.

-0.08

Correlation (All Time)
Calculated using the full available price history since Jun 23, 2017

0.05

The correlation between BIVRX and FSCEX shifts across timeframes, from -0.35 (1 year) to 0.05 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIVRX vs. FSCEX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

BIVRX
BIVRX Risk / Return Rank: 1414
Overall Rank
BIVRX Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
BIVRX Sortino Ratio Rank: 1717
Sortino Ratio Rank
BIVRX Omega Ratio Rank: 1515
Omega Ratio Rank
BIVRX Calmar Ratio Rank: 1313
Calmar Ratio Rank
BIVRX Martin Ratio Rank: 1212
Martin Ratio Rank

FSCEX
FSCEX Risk / Return Rank: 7171
Overall Rank
FSCEX Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
FSCEX Sortino Ratio Rank: 6666
Sortino Ratio Rank
FSCEX Omega Ratio Rank: 5656
Omega Ratio Rank
FSCEX Calmar Ratio Rank: 8686
Calmar Ratio Rank
FSCEX Martin Ratio Rank: 8484
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

BIVRX vs. FSCEX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and Fidelity Advisor Small Cap Fund Class C (FSCEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BIVRXFSCEXDifference
Sharpe ratioReturn per unit of total volatility

-1.07

Sortino ratioReturn per unit of downside risk

-1.34

Omega ratioGain probability vs. loss probability

1.11

1.27

-0.16

Calmar ratioReturn relative to maximum drawdown

0.58

3.04

-2.46

Martin ratioReturn relative to average drawdown

1.57

10.68

-9.11

BIVRX vs. FSCEX - Sharpe Ratio Comparison

The current BIVRX Sharpe Ratio is 0.48, which is lower than the FSCEX Sharpe Ratio of 1.55. The chart below compares the historical Sharpe Ratios of BIVRX and FSCEX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BIVRX vs. FSCEX - Drawdown Comparison

The maximum BIVRX drawdown since its inception was -27.37%, smaller than the maximum FSCEX drawdown of -51.02%. Use the drawdown chart below to compare losses from any high point for BIVRX and FSCEX.


Loading charts...

Drawdown Indicators


BIVRXFSCEXDifference

Max Drawdown

Largest peak-to-trough decline

-27.37%

-51.02%

+23.65%

Max Drawdown (1Y)

Largest decline over 1 year

-26.97%

-9.37%

-17.60%

Max Drawdown (3Y)

Largest decline over 3 years

-27.37%

-41.37%

+14.00%

Max Drawdown (5Y)

Largest decline over 5 years

-27.37%

-41.37%

+14.00%

Max Drawdown (10Y)

Largest decline over 10 years

-41.37%

Current Drawdown

Current decline from peak

-5.65%

-4.41%

-1.24%

Average Drawdown

Average peak-to-trough decline

-6.20%

-12.64%

+6.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.91%

2.67%

+7.24%

Volatility

BIVRX vs. FSCEX - Volatility Comparison

Invenomic Fund (BIVRX) has a higher volatility of 17.69% compared to Fidelity Advisor Small Cap Fund Class C (FSCEX) at 4.40%. This indicates that BIVRX's price experiences larger fluctuations and is considered to be riskier than FSCEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BIVRXFSCEXDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.69%

4.40%

+13.29%

Volatility (6M)

Calculated over the trailing 6-month period

29.33%

13.99%

+15.34%

Volatility (1Y)

Calculated over the trailing 1-year period

32.81%

18.38%

+14.43%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.09%

23.33%

-3.24%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.04%

22.57%

-3.53%

BIVRX vs. FSCEX - Expense Ratio Comparison

BIVRX has a 2.48% expense ratio, which is higher than FSCEX's 2.04% expense ratio.


Dividends

BIVRX vs. FSCEX - Dividend Comparison

BIVRX's dividend yield for the trailing twelve months is around 1.79%, less than FSCEX's 3.00% yield.


PositionTTM20252024202320222021202020192018201720162015
BIVRX
Invenomic Fund
1.79%1.93%3.55%20.26%28.43%3.00%3.11%3.21%4.82%1.21%0.00%0.00%
FSCEX
Fidelity Advisor Small Cap Fund Class C
3.00%3.58%0.00%2.23%8.66%16.35%3.97%5.72%20.54%18.60%2.60%10.50%

Frequently Asked Questions


BIVRX and FSCEX have a correlation of -0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BIVRX has higher volatility (17.69%) compared to FSCEX (4.40%). In terms of maximum drawdown, BIVRX dropped -27.37% vs FSCEX's -51.02%.

FSCEX currently has the higher Sharpe Ratio (1.55 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BIVRX and FSCEX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer